Close this search box.

Seventeen Minutes of Science: Biotechnology in the Time of COVID with Dr. Jeremy Levin

Tune in weekly to our virtual series “Seventeen Minutes of Science” every Tuesday at 11am PST / 2pm ET where we go live on Facebook with a new guest each week to talk about how science and biotechnology is woven into their lives for (you guessed it) 17 minutes!

For episode 26 of 17 Minutes of Science, we are joined by Dr. Jeremy Levin. Dr Levin is the current chairman and CEO of Ovid Therapeutics, Inc., a company working to bring impactful treatments to patients who have rare neurological conditions. Dr. Levin is also the chairman of the Biotechnology Innovation Organization (BIO) and was named by FierceBiotech in 2018 as one fo the most influential people in biopharma. Additionally, Dr. Levin recently published a book, Biotechnology in the Time of COVID.

Dr. Levin joins us on 17 Minutes of Science to discuss his recent book and to dig a bit deeper into the impact of the current coronavirus pandemic on biotech, biopharma, and clinical trials.

About The Author

InVivo Biosystems

InVivo Biosystems provides essential services to help pharmaceutical, nutraceutical, biotechnology companies and academic research institutions around the globe accelerate their research and drug development efforts. An expert in CRISPR genome editing, InVivo Biosystems creates custom genome edited C. elegans and zebrafish models to enable aging and other disease studies. In addition, InVivo Biosystems provides in-vivo analytical services to produce data and insights for companies that need to make go/no-go decisions quickly in early-stage development of new compounds.

Share this articles

Picture of InVivo Biosystems

About the Author:

Connect with us